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Introduction
Sudden changes in coronary plaque luminal surface morphology 
consisting of plaque rupture or fissure have been recognized as im-
portant mechanisms of acute coronary syndrome (ACS). Plaque dis-
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ruption is a reflection of enhanced inflammatory activity within the 
plaque, and the risk of plaque rupture has been shown to be asso-
ciated with plaque composition, which includes a large lipid core, a 
thin fibrous cap, and a high count of macrophages.
1)2) The ability to 
visualize and quantify the different components of atherosclerotic 
lesions provides important information not only on the mechanism 
of coronary artery disease (CAD) but also on potential future thera-
peutic interventions to alter the disease process.
3) Recently, virtual 
histology intravascular ultrasonography (VH-IVUS) using spectral 
analysis of radiofrequency ultrasound backscatter signals was intro-
duced to clinical practice to characterize plaque composition.
4)
The low density lipoprotein-cholesterol (LDL-C)/high density lipo-
protein-cholesterol (HDL-C) ratio is a predictor of CAD risk and a sur-
rogate marker of lipid-lowering therapies.
5) Meta-analysis data from 
4 studies using conventional IVUS has indicated a positive linear cor-
relation between achieved LDL-C/HDL-C ratio and percent volume 
changes of coronary plaque burden.
6) Moreover, Kimura et al.
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ported that an elevated LDL-C/HDL-C ratio may be a positive pre-
dictor for coronary lipid-rich plaques and plaque vulnerability in pa-
tients with chronic CAD. However, few reports have evaluated any 
link between the types of CAD, coronary plaque vulnerability, and 
blood lipid profiles.
Therefore, the purpose of this study was to determine the char-
acteristics of coronary plaque tissue and to examine the relationship 
between coronary plaque tissue according to lipid profile charac-
teristics visualized with VH-IVUS and lipid profiles in patients with 
stable angina pectoris (SAP).
Subjects and Methods
Study population
This study was a retrospective, single-center study. From August 
2007 to December 2010, we identified 266 consecutive patients 
(61.7±9.2 years, 174 males) with SAP who underwent coronary an-
giography (CAG) and VH-IVUS for target lesions before percutane-
ous coronary intervention (PCI). The presence of SAP was determin-
ed by typical effort-induced chest pain which was relieved by rest-
ing. Patients were divided into an unstable plaque (UP) group (61.6± 
9.2 years, 24 males, n=34) and a stable plaque (SP) group (61.7±9.2 
years, 150 males, n=232). UPs are characterized by thin-cap fibro-
atheroma (TCFA), ruptured plaque, or remaining thrombus on VH-
IVUS. The inclusion criterion was elective PCI in a de novo lesion due 
to symptomatic CAD without any prior history of PCI. In patients 
with single-vessel disease, the most severe lesion was considered 
the target lesion. In patients with multivessel disease and angina, 
the selection was determined by the combination of left ventricular 
wall motion abnormalities, electrocardiographic findings, single-
photon emission computed tomography, and the closest corresp-
onding coronary vessel containing the most severe lesion. We ex-
cluded patients with restenosis after PCI, coronary artery bypass gr-
afting, total occlusions, bifurcation lesions, lesions with severe an-
gulations, and heavily calcified lesions.
Laboratory analysis
Fasting blood sampling was obtained for measuring lipid pro-
files, high sensitivity C-reactive protein (hs-CRP), and creatinine be-
fore CAG. The serum levels of total cholesterol, LDL-C, HDL-C, and 
triglyceride were measured by standard enzymatic methods. hs-
CRP was analyzed turbidimetrically using sheep antibodies against 
human CRP; this has been validated against the Dade-Behring me-
thod.
8) Lipoprotein A {Lp(a)} was measured by an immunonephe-
lometric assay using a latex Lp(a) reagent composed of polystyrene 
particles coated with a rabbit anti-human Lp(a) γ-globulin fraction. 
Apolipoprotein A1, apolipoprotein B, and Lp(a) were measured using 
a Behring Nephelometer II (Dade Behring Inc., Deerfield, IL, USA).
Quantitative coronary angiography analysis
Coronary angiogram was analyzed with a validated quantitative 
coronary angiography (QCA) system (Philips H5000 or Allura DCI 
program, Philips Medical System, Eindhoven, the Netherlands). With 
the outer diameter of the contrast-filled catheter as the calibration 
standard, the minimal lumen diameter, reference diameter, and diame-
ter stenosis were measured in diastolic frames from orthogonal pro-
jections.
Intravascular ultrasonography imaging and analysis
Virtual histology intravascular ultrasonography examination was 
performed before any intervention and after intracoronary adminis-
tration of nitroglycerin 200 μg using a motorized transducer pull-
back system (0.5 mm/s). A 2.9 Fr IVUS imaging catheter (Eagle Eye; 
Volcano Corporation, Rancho Cordova, CA, USA) incorporated a 20 
MHz phased-array transducer.
Conventional gray-scale quantitative IVUS analyses were per-
formed according to the American College of Cardiology Clinical Ex-
pert Consensus Document on Standards for Acquisition, Measure-
ment, and Reporting of Intravascular Ultrasound Studies.
9) Percent 
plaque area of the minimum luminal area (MLA) was defined as the 
plaque and media area divided by the external elastic membrane 
(EEM) area. A remodeling index (RI) was calculated as the lesion 
EEM divided by the mean reference EEM area. The IVUS sign of pla-
que rupture was a cavity that communicated with the lumen with 
an overlying residual fibrous cap fragment.
10)11) Thrombus was an in-
traluminal mass having a layered or lobulated appearance, evid-
ence of blood flow (microchannels) within the mass, and speckling 
or scintillation.
9)12) VH-IVUS analysis classified tissue into four major 
color-coded components: green (fibrotic), yellow-green (fibro-fatty), 
white (dense calcium), and red {necrotic core (NC)}. VH-IVUS analy-
sis was reported in absolute amounts and as a percentage of plaque 
area. VH-IVUS-derived TCFA was defined as a NC ≥10% of plaque 
area at the MLA site in ≥3 consecutive frames without evident over-
lying fibrous tissue in the presence of ≥40% plaque burden.
13)
Statistical analysis
The Statistical Package for Social Sciences for Windows, version 
15.0 (Chicago, IL, USA) was used for all analyses. Continuous vari-
ables were presented as mean±standard deviations, and differenc-
es between the 2 groups were evaluated by the Student’s t-test. 
Categorical variables were presented as numbers (percentages), 
and comparisons across the 2 groups were performed by the chi-
square test or Fisher’s exact test. A multivariate logistic regression 
analysis was used to assess the independent predictors of UP. Pa-248  Coronary Plaque in Stable Angina
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tient baseline variables were entered into the regression model if 
they were statistically significant (p<0.2) by univariate analysis. All 
analyses were 2-tailed with clinical significance defined as values 
of p<0.05.
Results
Patient baseline characteristics
Two hundred sixty-six consecutive SAP patients were enrolled in 
the study. Thirty-four patients had a diagnosis of UP, and 232 had 
SP. HDL-C, LDL-C/HDL-C ratio >2.0 and Apolipoprotein A1 were sig-
nificantly lower in the UP group than in the SP group, whereas other 
variables in the 2 groups were similar (Table 1).
Coronary angiography and intravascular ultrasonography
findings
Quantitative coronary angiography showed that the target artery of 
the left main was more common in the UP group than in the SP 
group (20.6% vs. 7.3%, p=0.012), the minimal luminal diameter (MLD) 
was significantly smaller in the UP group than in the SP group (0.7± 
0.4 mm vs. 1.0±0.4 mm, p=0.004), and the stenosis diameter (SD) 
was significantly higher in the UP group than in the SP group (79.0± 
11.0% vs. 70.3±13.0%, p=0.001) (Table 2).
Gray-scale IVUS showed that the EEM cross-sectional area (CSA) 
Table 1. Patient baseline characteristics
UP (n=34) SP (n=232) p
Age (years) 61.6±9.2 61.7±9.2 0.966
Male gender, n (%) 24 (70) 150 (64) 0.497
Hypertension, n (%) 23 (67) 135 (58) 0.294
Diabetes mellitus, n (%) 14 (41) 75 (32) 0.307
Smoking, n (%) 6 (17) 54 (23) 0.463
Waist circumference (cm) 92.9±8.6 91.3±9.5 0.357
Body mass index (kg/m
2) 25.9±2.4 25.2±2.8 0.139
Total cholesterol (mg/dL) 180.2±36.1 181.8±37.6 0.821
Triglyceride (mg/dL) 122.4±96.7 127.6±96.9 0.773
LDL-C (mg/dL) 119.6±30.0 115.3±32.2 0.463
HDL-C (mg/dL) 41.2±8.5 46.0±11.8 0.006
LDL-C/HDL-C ratio >2.0, n (%) 31 (93) 158 (69) 0.003
Apolipoprotein A1 (mg/dL) 117.1±16.2 125.4±20.9 0.030
Apolipoprotein B (mg/dL) 92.1±18.5 91.0±21.3 0.759
Apolipoprotein B/A1 0.80±0.17 0.75±0.22 0.223
Lipoprotein A (mg/dL) 20.8±17.9 25.7±23.8 0.277
Homocysteine (μmol/L) 10.9±4.9 9.7±3.8 0.109
Hemoglobin A1c (g/dL) 6.5±1.6 6.2±1.1 0.327
Glucose (mg/dL) 129.7±51.5 132.6±49.3 0.768
Creatinine (mg/dL) 0.88±0.29 0.83±0.24 0.306
hs-CRP (mg/dL) 0.33±1.03 0.25±0.81 0.631
UP: unstable plaque, SP: stable plaque, LDL-C: low density lipoprotein-cho-
lesterol, HDL-C: high density lipoprotein-cholesterol, hs-CRP: high-sensitivity 
C-reactive protein
Table 2. Coronary angiography findings
UP (n=34) SP (n=232) p
Target artery, n (%)
Left main 7 (20.6) 17 (7.3) 0.012
Left anterior descending 23 (67.6) 173 (74.6) 0.392
Left circumflex 2 (5.9) 21 (9.1) 0.539
Right coronary artery 2 (5.9) 21 (9.1) 0.539
QCA
Proximal RD (mm) 3.5±0.5 3.3±0.4 0.090
MLD (mm) 0.7±0.4 1.0±0.4 0.004
Distal RD (mm) 3.1±1.0 3.0±0.7 0.733
Diameter stenosis (%) 79.0±11.0 70.3±13.0 0.001
UP: unstable plaque, SP: stable plaque, QCA: quantitative coronary angiog-
raphy, RD: reference diameter, MLD: minimal luminal diameter
Table 3. Grayscale and virtual histology IVUS findings
UP (n=34) SP (n=232) p
Grayscale IVUS data
Proximal reference
EEM CSA (mm
2) 18.1±5.8 16.5±4.0 0.178
Lumen CSA (mm
2) 10.3±3.9 9.2±2.3 0.171
Lesion
EEM CSA (mm
2) 18.0±6.7 13.1±3.9 0.001
Lumen CSA (mm
2) 3.8±1.4 3.7±1.4 0.644
Plaque area of MLA (%) 77.7±7.0 71.1±9.6 0.001
Distal reference
EEM CSA (mm
2) 13.7±6.6 11.0±4.0 0.037
Lumen CSA (mm
2) 8.4±4.0 7.6±2.6 0.294
Remodeling index 1.13±0.18 0.97±0.20 0.001
Thrombus, n (%) 4 (11) 0 (0) <0.001
Ruptured plaque, n (%) 22 (64) 0 (0) <0.001
Virtual histology IVUS data at MLA
Absolute areas (mm
2) 
Fibrotic 4.8±4.2 3.7±2.4 0.244
Fibrofatty 1.2±1.8 0.7±0.9 0.145
Dense calcium 0.8±0.4 0.8±0.6 0.990
Necrotic core 2.2±1.6 1.4±1.0 0.024
Percentages
Fibrotic 50.3±17.2 54.8±16.6 0.414
Fibrofatty 10.7±9.0 9.3±9.2 0.664
Dense calcium 11.3±5.7 14.0±12.2 0.482
Necrotic core 27.9±20.1 21.6±11.7 0.356
Thin-cap fibroatheroma 12 (35) 0 (0) <0.001
IVUS: intravascular ultrasound, UP: unstable plaque, SP: stable plaque, EEM: ex-
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of the lesion segment (18.0±6.7 mm
2 vs. 13.1±3.9 mm
2, p=0.001), 
percent plaque area of the MLA (77.7±7.0% vs. 71.1±9.6%, p= 
0.001), and the EEM CSA of the distal reference segment (13.7±6.6 
mm
2 vs. 11.0±4.0 mm
2, p=0.037) were significantly larger in the UP 
group than in the SP group. RI was significantly higher in the UP 
group than in the SP group (1.13±0.18 vs. 0.97±0.20, p=0.001), and 
target lesions in all patients contained 4 thrombi (1.5%) and 22 
ruptured plaques (8.3%). VH-IVUS showed that the NC area was 
significantly greater (2.2±1.6 mm
2 vs. 1.4±1.0 mm
2, p=0.024), and 
a tendency toward greater percentages of NC (27.9% vs. 21.6%, 
p=0.356) was present in the UP group. Target lesions in all patients 
contained 12 TCFAs (4.5%) (Table 3).
Multiple logistic regression analysis for predictive factors of 
unstable plaque in stable angina pectoris
Multiple logistic regression analysis was performed using LDL-C/
HDL-C ratio >2.0, body mass index, homocysteine, apolipoprotein 
A1, and HDL-C. In patients with SAP, LDL-C/HDL-C ratio >2.0 was 
the only independent predictor for UP (odds ratio 5.252, 95% con-
fidence interval 1.132-24.372, p=0.034) (Table 4).
Discussion
We evaluated the relationship between plaque vulnerability and 
lipid profiles using IVUS in patients with SAP. The present study 
showed that a high LDL-C/HDL-C ratio was a useful marker for UP 
in patients with SAP.
Coronary luminal stenosis as assessed by angiography has been 
considered a surrogate marker of atherosclerotic severity. However, 
CAG, a luminogram, has low predictive value to assess atheroscle-
rotic plaque burden or to predict ACS events.
14)15) Nevertheless, SAP 
patients have flow-limiting culprit lesions in their coronary arteries, 
and such lesions may be closely related to plaque vulnerability and 
plaque composition as a result of lower shear stress and endothelial 
dysfunction.
16) It is also well known that a vulnerable plaque rarely 
develops in <40% plaque volume. Therefore, a culprit lesion with a 
coronary blood flow limiting site may have a considerable relation 
to plaque vulnerability compared to a non-flow limiting lesion. Alth-
ough identification of mild/moderate vulnerable stenosis has the 
most relevant clinical implications, clinical validation and confirma-
tion of VH data on culprit lesions, which are the lesion subset best 
studied, are required.
Virtual histology intravascular ultrasonography has the potential 
to provide detailed qualitative and quantitative information; the iden-
tification of 4 specific plaque components has been validated in ex-
planted human coronary segments, as well as in retrieved directional 
coronary atherectomy specimens.
17)
The rupture of a vulnerable plaque and subsequent thrombus for-
mation are the most important mechanisms leading to ACS.
2)18) One 
angioscopic study reported that plaque rupture and subsequent 
thrombus formation were observed in 17% of SAP patients.
19) A 
study which investigated the relationship between clinical and an-
giographic observations with plaque rupture detected by IVUS has 
demonstrated that 22% of coronary plaques ruptured even in pa-
tients with stable angina or asymptomatic patients.
20) IVUS studies 
have reported varying frequencies of plaque rupture in SAP patients: 
15% by Hong et al.,
21) 18.5% by Hur
22) and 10.7% by Bae et al.
23) In 
the present study, 12.8% of SAP patients had plaques with vulner-
able characteristics.
It is well established that high serum levels of LDL-C constitute a 
strong predictor of CAD and that LDL-C-lowering therapy reduces 
CAD.
24) The LDL-C/HDL-C ratio was found to be more accurate in de-
termining CAD risk compared to LDL-C or HDL-C alone.
5)25) Based on 
data from clinical trials using conventional IVUS (REVERSAL, CAM-
EROT, ACTIVATE, and ASTEROID),
6)26-28) a high LDL-C/HDL-C ratio is as-
sociated with coronary plaque progression, while a low LDL-C/HDL-
C ratio achieved by pharmacological intervention is associated 
with coronary plaque regression. According to a subanalysis of the 
MEGA Study, which focused on primary prevention of cardiovascu-
lar events in a Japanese population, the incidence of cardiovascular 
events was significantly lower in those with an LDL-C/HDL-C ratio 
of 2.0 or lower than in those with an LDL-C/HDL-C ratio exceeding 
2.0 regardless of the HDL-C level.
29) Nicholls et al.
6) performed po-
oled analysis by integrating the data of 4 prospective, randomized 
trials using IVUS to assess plaque regression as a result of LDL-C 
lowering therapy for secondary prevention of CAD and demon-
strated that plaques were regressed by controlling the LDL-C/HDL-C 
ratio at 1.5 or lower. In the present study, an LDL-C/HDL-C ratio >2.0 
in patients with SAP was the independent predictor of plaques with 
vulnerable characteristics. In addition, the present study showed 
that the percent plaque area of MLA in high LDL-C/HDL-C ratio pa-
tients was significantly higher than in the low LDL-C/HDL-C ratio pa-
tients.
In the present study, characteristics of plaques detected using 
Table 4. Multiple logistic regression analysis for predictive factors of unsta-
ble plaque in SAP
OR 95% CI p
LDL-C/HDL-C ratio >2.0 5.252 1.132-24.372 0.034
Body mass index 1.116 0.966-1.289 0.135
Homocysteine 1.054 0.970-1.146 0.216
Apolipoprotein A1 0.981 0.948-1.015 0.272
HDL-C 1.015 0.948-1.088 0.665
SAP: stable angina pectoris, OR: odds ratio, CI: confidence interval, LDL-C: low 
density lipoprotein-cholesterol, HDL-C: high density lipoprotein-cholesterol250  Coronary Plaque in Stable Angina
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IVUS were associated with the LDL-C/HDL-C ratio. Therefore, incre-
ased LDL-C/HDL-C ratio represented by an increase in LDL-C and/
or decrease in HDL-C might increase the percent plaque area of MLA 
and may be a useful predictor for plaque vulnerability, which is a 
potent predictor of future cardiovascular events. However, further 
investigations are needed to clarify this relationship.
Limitations
Several limitations exist in the present study. First, the present 
study was retrospective and consisted of a relatively small number 
of patients from a single center. Therefore, a larger scale, well-or-
ganized prospective study is needed. Second, IVUS imaging was 
performed at the discretion of the individual operators. Thus, these 
situations might lead to potential selection bias. Third, the IVUS im-
age was only a single slice at the MLD site of the target lesion. We 
believe, however, that flow-limiting lesions might be related to low 
shear stress and endothelial dysfunction in patients with CAD.
Conclusions
Blood LDL-C/HDL-C ratio is related to UP, especially in patients 
with SAP. An LDL-C/HDL-C ratio over 2.0 may be a positive predictor 
for coronary plaque vulnerability.
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